Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
May 28, 2009

Zeiss and Bruker Combine Technologies for Nontargeted Molecular Histology

  • Carl Zeiss will integrate its MIRAX Virtual Slide Scanner into Bruker Daltonics’ MALDI Molecular Imager™. In the past, a major bottleneck in pathology research has been the interpretation of MALDI imaging results in a histological context. Combining the two technologies, the companies report, allows the direct overlay of the full microscopic image with the entire molecular and spectral information in one visualization software tool, enabling untargeted molecular histology.

    The MALDI Molecular Imager allows histology researchers to measure spatially resolved peptide, protein, and lipid profiles in tissue sections. Zeiss Mirax Scanner is scalable online and has a high-lateral resolution that can zoom in to any tissue sections investigated by MALDI.



Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »